FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242934846> ?p ?o ?g. }

• W4242934846 endingPage "1354" @default.
• W4242934846 startingPage "1354" @default.
• W4242934846 abstract "Potential conflict of interest: Nothing to report. We welcome the comments from Huang and Lee on our meta‐analysis of surface antibody in hepatitis B virus (HBV) reactivation. First, as mentioned in our Table 1 footnote, our definition of HBV reactivation incorporated the broad range of outcomes reported in the literature: detectable HBV DNA, HBV detection with or without conversion from hepatitis B surface antigen (HBsAg) negative to positive, HBV DNA >10 IU/mL, HBV DNA > 10‐fold increase versus previous nadir, or conversion from HBsAg‐negative to HBsAg‐positive.1 Their reported elevation of HBV viral load to >2,000 IU/mL from baseline2 satisfied our HBV detection criterion for reactivation. Second, we agree with Huang and Lee that the incidence of HBV reactivation occurs more frequently as a detectable HBV DNA level than as HBsAg reverse seroconversion in patients receiving rituximab therapy. In our meta‐analysis of patients receiving rituximab therapy, reactivation only occurred as detectable HBV DNA without any reported cases of HBsAg reverse seroconversion. Although Huang and Lee mention that we may have overlooked the risk of HBV reactivation in patients with hepatitis B surface antibody undergoing rituximab therapy, we did include that study3 in our meta‐analysis as citation 22. Additionally, our discussion specifically mentions that the presence of hepatitis B surface antibody reduces but does not eliminate the risk of HBV reactivation. Our meta‐analysis suggests that patients with hepatitis B surface antibody still have a 5.6% residual risk of reactivation, so we would recommend antiviral prophylaxis in these patients. Lastly, we agree that heterogeneity among studies is a potential limitation of any meta‐analysis. Grouping studies with concordant outcomes would have reduced the power to detect statistically significant results, with four studies using detectable HBV DNA, six studies using HBV detection with or without conversion from HBsAg negative to positive, two studies using HBV DNA >10 IU/mL, seven studies using HBV DNA >10‐fold increase versus previous nadir, and one study using conversion from HBsAg‐negative to HBsAg‐positive. Despite the differences in outcome measures, the I2 test for heterogeneity4 was 0% among all analyses, suggesting no inconsistency in the results across studies." @default.
• W4242934846 created "2022-05-12" @default.
• W4242934846 creator A5076888046 @default.
• W4242934846 date "2017-08-26" @default.
• W4242934846 modified "2023-09-27" @default.
• W4242934846 title "Reply" @default.
• W4242934846 cites W2140505684 @default.
• W4242934846 cites W2147134417 @default.
• W4242934846 cites W2582667894 @default.
• W4242934846 doi "https://doi.org/10.1002/hep.29355" @default.
• W4242934846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28688162" @default.
• W4242934846 hasPublicationYear "2017" @default.
• W4242934846 type Work @default.
• W4242934846 citedByCount "0" @default.
• W4242934846 crossrefType "journal-article" @default.
• W4242934846 hasAuthorship W4242934846A5076888046 @default.
• W4242934846 hasBestOaLocation W42429348461 @default.
• W4242934846 hasConcept C126322002 @default.
• W4242934846 hasConcept C159047783 @default.
• W4242934846 hasConcept C159654299 @default.
• W4242934846 hasConcept C203014093 @default.
• W4242934846 hasConcept C2522874641 @default.
• W4242934846 hasConcept C2777382497 @default.
• W4242934846 hasConcept C2777410769 @default.
• W4242934846 hasConcept C2777451964 @default.
• W4242934846 hasConcept C2780593183 @default.
• W4242934846 hasConcept C2780653079 @default.
• W4242934846 hasConcept C71924100 @default.
• W4242934846 hasConceptScore W4242934846C126322002 @default.
• W4242934846 hasConceptScore W4242934846C159047783 @default.
• W4242934846 hasConceptScore W4242934846C159654299 @default.
• W4242934846 hasConceptScore W4242934846C203014093 @default.
• W4242934846 hasConceptScore W4242934846C2522874641 @default.
• W4242934846 hasConceptScore W4242934846C2777382497 @default.
• W4242934846 hasConceptScore W4242934846C2777410769 @default.
• W4242934846 hasConceptScore W4242934846C2777451964 @default.
• W4242934846 hasConceptScore W4242934846C2780593183 @default.
• W4242934846 hasConceptScore W4242934846C2780653079 @default.
• W4242934846 hasConceptScore W4242934846C71924100 @default.
• W4242934846 hasIssue "4" @default.
• W4242934846 hasLocation W42429348461 @default.
• W4242934846 hasLocation W42429348462 @default.
• W4242934846 hasLocation W42429348463 @default.
• W4242934846 hasOpenAccess W4242934846 @default.
• W4242934846 hasPrimaryLocation W42429348461 @default.
• W4242934846 hasRelatedWork W1506797373 @default.
• W4242934846 hasRelatedWork W1826111040 @default.
• W4242934846 hasRelatedWork W1986044171 @default.
• W4242934846 hasRelatedWork W2057160759 @default.
• W4242934846 hasRelatedWork W2061734351 @default.
• W4242934846 hasRelatedWork W2210580309 @default.
• W4242934846 hasRelatedWork W2263815274 @default.
• W4242934846 hasRelatedWork W2412694559 @default.
• W4242934846 hasRelatedWork W2793771454 @default.
• W4242934846 hasRelatedWork W3152227415 @default.
• W4242934846 hasVolume "66" @default.
• W4242934846 isParatext "false" @default.
• W4242934846 isRetracted "false" @default.
• W4242934846 workType "article" @default.